Codexis (CDXS) Tops Q4 EPS by 15c, Beats on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. AMD

Go back to Codexis (CDXS) Tops Q4 EPS by 15c, Beats on Revenue

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

March 11, 2026 4:05 PM EDT

     Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025

Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027

Completed $37.8 million Technology Transfer Agreement with Merck

REDWOOD CITY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update.

... More